Evidence map›Paper›PMID 35200331›Full record

ArticleBiosensors2022

Detection of Liver Dysfunction Using a Wearable Electronic Nose System Based on Semiconductor Metal Oxide Sensors.

Andreas Voss, Rico Schroeder, Steffen Schulz, Jens Haueisen, Stefanie Vogler, Paul Horn, Andreas Stallmach, Philipp Reuken

Abstract read
In one paragraph

Article in Biosensors, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Andreas VossInstitute of Innovative Health Technologies IGHT, Ernst-Abbe-Hochschule Jena, 07745 Jena, Germany.
Rico SchroederInstitute of Innovative Health Technologies IGHT, Ernst-Abbe-Hochschule Jena, 07745 Jena, Germany.ORCID 0000-0003-3076-4450
Steffen SchulzInstitute of Innovative Health Technologies IGHT, Ernst-Abbe-Hochschule Jena, 07745 Jena, Germany.
Jens HaueisenInstitute of Biomedical Engineering and Informatics (BMTI), Technische Universität Ilmenau, 98693 Ilmenau, Germany.ORCID 0000-0003-3871-2890
Stefanie VoglerClinic for Internal Medicine IV, University Hospital Jena, 07747 Jena, Germany.
Paul HornClinic for Internal Medicine IV, University Hospital Jena, 07747 Jena, Germany.ORCID 0000-0002-8755-7703
Andreas StallmachClinic for Internal Medicine IV, University Hospital Jena, 07747 Jena, Germany.ORCID 0000-0002-6101-5244
Philipp ReukenClinic for Internal Medicine IV, University Hospital Jena, 07747 Jena, Germany.ORCID 0000-0002-7696-475X

Funding

European Regional Development Fund withoutFederal Ministry for Economic Affairs and Energy ZF4485201SB7Thuringian Ministry of Economy, Labor and Technology TMBWAT/TAB 20018
6 · The paper itself

Abstract

The purpose of this exploratory study was to determine whether liver dysfunction can be generally classified using a wearable electronic nose based on semiconductor metal oxide (MOx) gas sensors, and whether the extent of this dysfunction can be quantified. MOx gas sensors are attractive because of their simplicity, high sensitivity, low cost, and stability. A total of 30 participants were enrolled, 10 of them being healthy controls, 10 with compensated cirrhosis, and 10 with decompensated cirrhosis. We used three sensor modules with a total of nine different MOx layers to detect reducible, easily oxidizable, and highly oxidizable gases. The complex data analysis in the time and non-linear dynamics domains is based on the extraction of 10 features from the sensor time series of the extracted breathing gas measurement cycles. The sensitivity, specificity, and accuracy for distinguishing compensated and decompensated cirrhosis patients from healthy controls was 1.00. Patients with compensated and decompensated cirrhosis could be separated with a sensitivity of 0.90 (correctly classified decompensated cirrhosis), a specificity of 1.00 (correctly classified compensated cirrhosis), and an accuracy of 0.95. Our wearable, non-invasive system provides a promising tool to detect liver dysfunctions on a functional basis. Therefore, it could provide valuable support in preoperative examinations or for initial diagnosis by the general practitioner, as it provides non-invasive, rapid, and cost-effective analysis results.

Indexed as

Electronic NoseWearable Electronic DevicesBiosensing TechniquesHumansLiver CirrhosisMetalsOxidesSemiconductorsMetalsOxidescirrhosiselectronic noseliver dysfunctionsemiconductor metal oxide gas sensor

Identifiers

PMID35200331
PMCPMC8869535

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.